Clinical Trial Update: Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement [NA]

View source ↗

Summary

This is a completed study evaluating Cardea SOLO for diagnosing paroxysmal atrial fibrillation in patients with embolic stroke of undetermined source and left a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Embolic Stroke of Undetermined Source
• Paroxysmal Atrial Fibrillation

Drugs mentioned

• Cardea SOLOTM

Snippet

Sponsor: Asan Medical Center | Conditions: Embolic Stroke of Undetermined Source | NA | Status: COMPLETED